40 related articles for article (PubMed ID: 14966129)
1. Crystal structures of human bifunctional enzyme aminoimidazole-4-carboxamide ribonucleotide transformylase/IMP cyclohydrolase in complex with potent sulfonyl-containing antifolates.
Cheong CG; Wolan DW; Greasley SE; Horton PA; Beardsley GP; Wilson IA
J Biol Chem; 2004 Apr; 279(17):18034-45. PubMed ID: 14966129
[TBL] [Abstract][Full Text] [Related]
2. Characterization of AICAR transformylase/IMP cyclohydrolase (ATIC) bifunctional enzyme from Candidatus Liberibacer asiaticus.
Lonare S; Rode S; Verma P; Verma S; Kaur H; Alam MS; Wangmo P; Kumar P; Roy P; Sharma AK
Biochim Biophys Acta Proteins Proteom; 2024 Jul; 1872(4):141015. PubMed ID: 38615986
[TBL] [Abstract][Full Text] [Related]
3. Colocalization and Sequential Enzyme Activity in Aqueous Biphasic Systems: Experiments and Modeling.
Davis BW; Aumiller WM; Hashemian N; An S; Armaou A; Keating CD
Biophys J; 2015 Nov; 109(10):2182-94. PubMed ID: 26588576
[TBL] [Abstract][Full Text] [Related]
4. Structure-Based Design of Transport-Specific Multitargeted One-Carbon Metabolism Inhibitors in Cytosol and Mitochondria.
Nayeen MJ; Katinas JM; Magdum T; Shah K; Wong JE; O'Connor CE; Fifer AN; Wallace-Povirk A; Hou Z; Matherly LH; Dann CE; Gangjee A
J Med Chem; 2023 Aug; 66(16):11294-11323. PubMed ID: 37582241
[TBL] [Abstract][Full Text] [Related]
5. Multitargeted 6-Substituted Thieno[2,3-
Tong N; Wong-Roushar J; Wallace-Povirk A; Shah Y; Nyman MC; Katinas JM; Schneider M; O'Connor C; Bao X; Kim S; Li J; Hou Z; Matherly LH; Dann CE; Gangjee A
ACS Pharmacol Transl Sci; 2023 May; 6(5):748-770. PubMed ID: 37200803
[TBL] [Abstract][Full Text] [Related]
6. Survival-Associated Metabolic Genes and Risk Scoring System in HER2-Positive Breast Cancer.
Gao C; Li H; Zhou C; Liu C; Zhuang J; Liu L; Sun C
Front Endocrinol (Lausanne); 2022; 13():813306. PubMed ID: 35663326
[TBL] [Abstract][Full Text] [Related]
7. Current Status of the Use of Multifunctional Enzymes as Anti-Cancer Drug Targets.
Teixeira CSS; Sousa SF
Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056904
[TBL] [Abstract][Full Text] [Related]
8. A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight.
Cuthbertson CR; Arabzada Z; Bankhead A; Kyani A; Neamati N
ACS Pharmacol Transl Sci; 2021 Apr; 4(2):624-646. PubMed ID: 33860190
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 6-substituted thieno[2,3-d]pyrimidine analogs as dual inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase in de novo purine nucleotide biosynthesis in folate receptor expressing human tumors.
Wallace-Povirk A; Tong N; Wong-Roushar J; O'Connor C; Zhou X; Hou Z; Bao X; Garcia GE; Li J; Kim S; Dann CE; Matherly LH; Gangjee A
Bioorg Med Chem; 2021 May; 37():116093. PubMed ID: 33773393
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a novel AICARFT inhibitor which potently elevates ZMP and has anti-tumor activity in murine models.
Brooks HB; Meier TI; Geeganage S; Fales KR; Thrasher KJ; Konicek SA; Spencer CD; Thibodeaux S; Foreman RT; Hui YH; Roth KD; Qian YW; Wang T; Luo S; Torrado A; Si C; Toth JL; Mc Cowan JR; Frimpong K; Lee MR; Dally RD; Shepherd TA; Durham TB; Wang Y; Wu Z; Iversen PW; Njoroge FG
Sci Rep; 2018 Oct; 8(1):15458. PubMed ID: 30337562
[TBL] [Abstract][Full Text] [Related]
11. Utility of the Biosynthetic Folate Pathway for Targets in Antimicrobial Discovery.
Bourne CR
Antibiotics (Basel); 2014 Jan; 3(1):1-28. PubMed ID: 27025730
[TBL] [Abstract][Full Text] [Related]
12. The last enzyme of the de novo purine synthesis pathway 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC) plays a central role in insulin signaling and the Golgi/endosomes protein network.
Boutchueng-Djidjou M; Collard-Simard G; Fortier S; Hébert SS; Kelly I; Landry CR; Faure RL
Mol Cell Proteomics; 2015 Apr; 14(4):1079-92. PubMed ID: 25687571
[TBL] [Abstract][Full Text] [Related]
13. Novel 5-substituted pyrrolo[2,3-d]pyrimidines as dual inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase and as potential antitumor agents.
Wang Y; Mitchell-Ryan S; Raghavan S; George C; Orr S; Hou Z; Matherly LH; Gangjee A
J Med Chem; 2015 Feb; 58(3):1479-93. PubMed ID: 25602637
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive identification of host modulators of HIV-1 replication using multiple orthologous RNAi reagents.
Zhu J; Davoli T; Perriera JM; Chin CR; Gaiha GD; John SP; Sigiollot FD; Gao G; Xu Q; Qu H; Pertel T; Sims JS; Smith JA; Baker RE; Maranda L; Ng A; Elledge SJ; Brass AL
Cell Rep; 2014 Oct; 9(2):752-66. PubMed ID: 25373910
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 5-substituted pyrrolo[2,3-d]pyrimidine antifolates as dual-acting inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase in de novo purine nucleotide biosynthesis: implications of inhibiting 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase to ampk activation and antitumor activity.
Mitchell-Ryan S; Wang Y; Raghavan S; Ravindra MP; Hales E; Orr S; Cherian C; Hou Z; Matherly LH; Gangjee A
J Med Chem; 2013 Dec; 56(24):10016-10032. PubMed ID: 24256410
[TBL] [Abstract][Full Text] [Related]
16. Biological and structural evaluation of 10R- and 10S-methylthio-DDACTHF reveals a new role for sulfur in inhibition of glycinamide ribonucleotide transformylase.
Connelly S; DeMartino JK; Boger DL; Wilson IA
Biochemistry; 2013 Jul; 52(30):5133-44. PubMed ID: 23869564
[TBL] [Abstract][Full Text] [Related]
17. Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma.
Kelemen LE; Wang Q; Dinu I; Vierkant RA; Tsai YY; Cunningham JM; Phelan CM; Fridley BL; Amankwah EK; Iversen ES; Berchuck A; Schildkraut JM; Goode EL; Sellers TA
Front Genet; 2012; 3():33. PubMed ID: 22461784
[TBL] [Abstract][Full Text] [Related]
18. Classifying compound mechanism of action for linking whole cell phenotypes to molecular targets.
Bourne CR; Wakeham N; Bunce RA; Nammalwar B; Berlin KD; Barrow WW
J Mol Recognit; 2012 Apr; 25(4):216-23. PubMed ID: 22434711
[TBL] [Abstract][Full Text] [Related]
19. Expression, purification, crystallization and preliminary X-ray diffraction crystallographic study of PurH from Escherichia coli.
Qiu X; Yuan Y; Gao Y
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Dec; 67(Pt 12):1590-4. PubMed ID: 22139174
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
